These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39186212)

  • 1. Impact of High Covid-19 Vaccination Rate in an Aging Population: Estimating Averted Hospitalizations and Deaths in the Basque Country, Spain Using Counterfactual Modeling.
    Estadilla CDS; Mar J; Ibarrondo O; Stollenwerk N; Aguiar M
    J Epidemiol Glob Health; 2024 Sep; 14(3):1289-1299. PubMed ID: 39186212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct impact of COVID-19 vaccination in Chile: averted cases, hospitalizations, ICU admissions, and deaths.
    Brault A; Hart A; Uribe P; Prado J; San Martín J; Maass A; Canals M
    BMC Infect Dis; 2024 May; 24(1):467. PubMed ID: 38698324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the COVID-19 vaccination programme on symptomatic and severe SARS-CoV-2 infection during a period of Omicron variant dominance in Ireland, December 2021 to March 2023.
    Marron L; Mateo-Urdiales A; O'Donnell J; Robinson E; Domegan L
    Euro Surveill; 2024 Jul; 29(28):. PubMed ID: 38994604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Vaccination and Incidence of Pediatric SARS-CoV-2 Infection and Hospitalization.
    Head JR; Collender PA; León TM; White LA; Sud SR; Camponuri SK; Lee V; Lewnard JA; Remais JV
    JAMA Netw Open; 2024 Apr; 7(4):e247822. PubMed ID: 38652476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Sonabend R; Whittles LK; Imai N; Perez-Guzman PN; Knock ES; Rawson T; Gaythorpe KAM; Djaafara BA; Hinsley W; FitzJohn RG; Lees JA; Kanapram DT; Volz EM; Ghani AC; Ferguson NM; Baguelin M; Cori A
    Lancet; 2021 Nov; 398(10313):1825-1835. PubMed ID: 34717829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
    Haas EJ; McLaughlin JM; Khan F; Angulo FJ; Anis E; Lipsitch M; Singer SR; Mircus G; Brooks N; Smaja M; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet Infect Dis; 2022 Mar; 22(3):357-366. PubMed ID: 34562375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran.
    Ghafari M; Hosseinpour S; Rezaee-Zavareh MS; Dascalu S; Rostamian S; Aramesh K; Madani K; Kordasti S
    BMC Med; 2023 Nov; 21(1):429. PubMed ID: 37953291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.
    Patel MD; Rosenstrom E; Ivy JS; Mayorga ME; Keskinocak P; Boyce RM; Hassmiller Lich K; Smith RL; Johnson KT; Delamater PL; Swann JL
    JAMA Netw Open; 2021 Jun; 4(6):e2110782. PubMed ID: 34061203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021.
    Steele MK; Couture A; Reed C; Iuliano D; Whitaker M; Fast H; Hall AJ; MacNeil A; Cadwell B; Marks KJ; Silk BJ
    JAMA Netw Open; 2022 Jul; 5(7):e2220385. PubMed ID: 35793085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High vaccine effectiveness against severe COVID-19 outcomes and population preventable fraction during the Omicron era in Luxembourg: A nationwide retrospective risk factor analysis.
    Bejko D; Ernst C; Vergison A; Stranges S; Zeegers MP; Mossong J
    Vaccine; 2024 Sep; 42(22):126011. PubMed ID: 38825555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoidable COVID-19-related deaths and hospitalizations in Brazil, 2020-2023.
    Kupek E
    Vaccine; 2024 May; 42(15):3437-3444. PubMed ID: 38631953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the first year of COVID-19 vaccination strategy in Brazil: an ecological study.
    Aguilar S; Bastos LSL; Maçaira P; Baião F; Simões P; Cerbino-Neto J; Ranzani O; Hamacher S; Bozza FA
    BMJ Open; 2024 Jul; 14(7):e072314. PubMed ID: 38964793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of mRNA booster doses in preventing infections and hospitalizations due to SARS-CoV-2 and its dominant variant over time in Valencian healthcare workers, Spain.
    Jiménez-Sepúlveda N; Gras-Valentí P; Chico-Sánchez P; Castro-García JM; Ronda-Pérez E; Vanaclocha H; Peiró S; Burgos JS; Ana Berenguer ; Navarro D; Sánchez-Payá J;
    Vaccine; 2024 Jul; 42(19):4011-4021. PubMed ID: 38760269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.
    Tran TN; Wikle NB; Albert E; Inam H; Strong E; Brinda K; Leighow SM; Yang F; Hossain S; Pritchard JR; Chan P; Hanage WP; Hanks EM; Boni MF
    BMC Med; 2021 Jul; 19(1):162. PubMed ID: 34253200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing New York City's COVID-19 Vaccine Rollout Strategy: A Case for Risk-Informed Distribution.
    Schwalbe N; Nunes MC; Cutland C; Wahl B; Reidpath D
    J Urban Health; 2024 Oct; 101(5):923-933. PubMed ID: 38578336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health impact of booster vaccination against COVID-19 in the UK during Delta variant dominance in autumn 2021.
    Mendes D; Chapman R; Gal P; Atwell J; Nguyen JL; Hamson L; Di Fusco M; Czudek C; Yang J
    J Med Econ; 2022; 25(1):1039-1050. PubMed ID: 36097853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.
    Rosenberg ES; Holtgrave DR; Dorabawila V; Conroy M; Greene D; Lutterloh E; Backenson B; Hoefer D; Morne J; Bauer U; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1150-1155. PubMed ID: 34437517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.
    Rosenberg ES; Holtgrave DR; Dorabawila V; Conroy M; Greene D; Lutterloh E; Backenson B; Hoefer D; Morne J; Bauer U; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2021 Sep; 70(37):1306-1311. PubMed ID: 34529645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the health impact of increasing vaccine coverage and nonpharmaceutical interventions against coronavirus disease 2019 in Ghana.
    Ofori SK; Schwind JS; Sullivan KL; Chowell G; Cowling BJ; Fung IC
    Pathog Glob Health; 2024 May; 118(3):262-276. PubMed ID: 38318877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.